TABLE 5.
Pearson product–moment correlations between changes in physiological outcomes and changes in inflammatory markers
| BMI (kg·m−2) | Cardiorespiratory Fitness (L·min−1) | Lower-Limb Muscle Strength (kg) | Handgrip Strength (kg) | |
|---|---|---|---|---|
| CASP-8 | −0.04 | −0.05 | −0.19 | −0.13 |
| CCL17 | −0.05 | −0.10 | −0.13 | −0.22** |
| CD8a | −0.11 | −0.06 | −0.23* | −0.18* |
| CD40-L | −0.07 | −0.07 | −0.11 | −0.14 |
| CSF-1 | −0.08 | −0.02 | −0.16 | −0.16 |
| CXCL9 | −0.14 | −0.01 | −0.04 | −0.03 |
| DCN | −0.004 | −0.21* | −0.13 | −0.03 |
| EGF | −0.05 | −0.03 | −0.11 | −0.19* |
| ICOSLG | −0.003 | −0.22* | −0.14 | −0.12 |
| IFN-y | −0.04 | −0.33** | −0.06 | −0.04 |
| IL-6 | −0.03 | −0.10 | −0.14 | −0.01 |
| IL-10 | −0.02 | −0.13 | −0.03 | −0.01 |
| MIC A/B | −0.10 | −0.02 | −0.14 | −0.16 |
| TRAIL | −0.14 | −0.10 | −0.13 | −0.16 |
*P < 0.10.
**P < 0.05.
CASP-8, caspase-8; CD40-L, CD40 ligand; CSF-1, macrophage colony stimulating factor 1; CXCL9, C-X-C motif chemokine 9; DCN, decorin; FasL, Fas antigen ligand; ICOSLG, ICOS ligand; MIC A/B, MHC class I polypeptide-related sequence A/B; TRAIL, TNF-related apoptosis-inducing ligand.